Associate Professor John Allan Appointed Chief Research Advisor

Share on facebook
Share on twitter
Share on linkedin

Experienced researcher and medical specialist, Associate Professor John Allan, has been appointed to the newly created role, Chief Research Advisor at Wesley Medical Research (WMR). 

He will commence in this new position in October 2018.

A long-standing Director of the WMR Board, A/ProfJohn Allan was appointed as the CEO in October 2017, working in an honorary capacity. He has spent the last twelve months implementing WMR’s new strategic direction and restructuring WMR to maximise the impact of donations towards practical outcomes for patients.

Mr Peter Allen, Chairman of the WMR Board of Directors, praised John for his achievements during his tenure as CEO and for his willingness to continue to serve WMR in this new role. “The realignment of the role of A/Prof John Allan allows him to focus on his main interests of medical research knowledge and improving patient outcomes.”

“I’m thrilled to be continuing my involvement in WMR’s research operations, as we have the vision and infrastructure to undertake some internationally competitive clinical research,” said A/Prof John Allan.   

“We have been fortunate to have retained the services of such a respected researcher and clinician. We are very grateful for his contribution as CEO and pleased he has accepted this critical new role,” Mr Peter Allen said. 

A/Prof John Allan will continue as a Director on the WMR Board.

More to explore...

Hope for Better Quality of Life for Tourette’s Patients

After trying a dozen different medications, Chris, a Brisbane man who was diagnosed with debilitating Tourette’s Syndrome at age 12, is part of an Australian-first medicinal cannabis trial. For the past 16 years, the condition has impacted all aspects of Chris’ life, including his mental health. This trial has offered Chris more than hope. It’s offered a future.

Read More »

Wesley Medical Research

Scroll to Top